# Sanofi Consumer Healthcare India Limited has announced robust Q4 financial results, demonstrating strong operational performance across key metrics.

*business · news · 2026-04-29 · scanx.trade*

## Key points

- Sanofi Consumer Healthcare India's Q4 net profit rose 35.6% to ₹678 million year-over-year.
- Domestic sales grew 15.5%, while export sales surged 144.4% on a low base this quarter.
- Product relaunches of Combiflam Suspension, Allegra Suspension, and Depura Kids significantly boosted domestic sales.
- The company recognized a ₹24 million expense due to new Indian Labour Codes affecting employee benefits.
- All four material related party and remuneration resolutions were approved with over 99.9% shareholder support.

**Companies:** Sanofi Consumer Healthcare India Limited
**Countries:** India

[Read the full story on scanx.trade](https://scanx.trade/stock-market-news/companies/sanofi-consumer-healthcare-india-reports-strong-q4-growth-with-35-6-profit-surge/38921283)

---

Canonical: https://newsio.io/n/1505244d-cfcc-42db-b403-ebeb658dd89d/sanofi-consumer-healthcare-india-limited-has-announced-robust-q4-financial-resul
Summarized by Newsio from scanx.trade. https://newsio.io/how-it-works